<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="8222" end="8227" sStart="8160" offset="62" sid="r7.1.use.v.0670" wn="1" wnkey="use%2:34:01::" text="Single-stranded cDNA was synthesized from total RNA using MMLV reverse transcriptase (Retroscript RT kit; Ambion, Inc., Austin, TX, USA)." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="20240" end="20245" sStart="null" offset="6" sid="r7.trace.v.0275" wn="2147483645" wnkey="null" text="While trace amounts were detected due to the sensitivity of PCR amplification, thrombospondin transcripts were essentially absent from breast tissue epithelia obtained from normal and benign specimens, and there were no appreciable levels detected in stromal tissue components." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="3339" end="3348" sStart="null" offset="931" sid="r8.suggest.v.0493" wn="1" wnkey="suggest%2:32:00::" text="TSP-1 is a homotrimeric multidomain glycoprotein synthesized and secreted by numerous cell types, including platelets, vascular smooth muscle cells and keratinocytes [ 4 ] . Due to its interaction with a wide variety of proteins, TSP-1 has been implicated in a number of biological processes including coagulation, cell adhesion, the modulation of cell-cell and cell-matrix interactions, control of tumor growth and metastasis, and angiogenesis [ 10 ] . Inhibition of tumor cell proliferation has been achieved in vivo by systemic treatment with TSP-1 peptide mimetics [ 11 ] , but a correlation between primary tumor TSP-1 expression and poor prognosis has not been clearly established [ 12 ] . While there are reports that these molecules can originate from tumor cells [ 13 ] , the majority of reports have suggested that the major source of both TSP-1 and OPN is tumor-associated stroma [ 14 ] or infiltrating macrophages and lymphocytes [ 15 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="119" end="125" sStart="null" offset="74" sid="r8.state.n.0892" wn="2147483647" wnkey="null" text="Breast cancer is a major cause of death among women in the United States and worldwide [ 1 ] . While cures are probable if the cancer is detected early and remains localized, many patients will succumb to the disease if the primary tumor metastasizes to secondary organs." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="3144" end="3148" sStart="null" offset="736" sid="r7.poor.j.0841" wn="4" wnkey="poor%3:00:02::" text="TSP-1 is a homotrimeric multidomain glycoprotein synthesized and secreted by numerous cell types, including platelets, vascular smooth muscle cells and keratinocytes [ 4 ] . Due to its interaction with a wide variety of proteins, TSP-1 has been implicated in a number of biological processes including coagulation, cell adhesion, the modulation of cell-cell and cell-matrix interactions, control of tumor growth and metastasis, and angiogenesis [ 10 ] . Inhibition of tumor cell proliferation has been achieved in vivo by systemic treatment with TSP-1 peptide mimetics [ 11 ] , but a correlation between primary tumor TSP-1 expression and poor prognosis has not been clearly established [ 12 ] . While there are reports that these molecules can originate from tumor cells [ 13 ] , the majority of reports have suggested that the major source of both TSP-1 and OPN is tumor-associated stroma [ 14 ] or infiltrating macrophages and lymphocytes [ 15 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="3144" end="3148" sStart="null" offset="736" sid="r7.poor.j.0841" wn="4" wnkey="poor%3:00:02::" text="TSP-1 is a homotrimeric multidomain glycoprotein synthesized and secreted by numerous cell types, including platelets, vascular smooth muscle cells and keratinocytes [ 4 ] . Due to its interaction with a wide variety of proteins, TSP-1 has been implicated in a number of biological processes including coagulation, cell adhesion, the modulation of cell-cell and cell-matrix interactions, control of tumor growth and metastasis, and angiogenesis [ 10 ] . Inhibition of tumor cell proliferation has been achieved in vivo by systemic treatment with TSP-1 peptide mimetics [ 11 ] , but a correlation between primary tumor TSP-1 expression and poor prognosis has not been clearly established [ 12 ] . While there are reports that these molecules can originate from tumor cells [ 13 ] , the majority of reports have suggested that the major source of both TSP-1 and OPN is tumor-associated stroma [ 14 ] or infiltrating macrophages and lymphocytes [ 15 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="33575" end="33581" sStart="null" offset="89" sid="null" wn="1" wnkey="normal%3:00:01::" text="The biological function of and any clinical significance of TYRP-1 expression in normal or malignant breast carcinomas are presently unknown." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="16490" end="16496" sStart="null" offset="288" sid="null" wn="1" wnkey="normal%3:00:01::" text="A high percentage of node-positive primary tumors (73%), metastatic carcinomas (73% and 100% concordance between primary tumor and associated metastasis, respectively), primary carcinomas without metastases (89%), benign breast specimens (70%) and normal (60%) breast specimens were positive for TYRP-1 staining (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="16103" end="16109" sStart="null" offset="62" sid="r9.normal.j.0653" wn="1" wnkey="normal%3:00:01::" text="Very weak staining was observed in fibroadenoma and normal tissues, and no TSP-1 was detected in breast tissue stromal components." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="23265" end="23271" sStart="null" offset="68" sid="r9.normal.j.0089" wn="1" wnkey="normal%3:00:01::" text="Having detected all three proteins immunohistochemically in normal, benign and malignant breast epithelia, the quantitation of OPN, TSP-1 and TYRP-1 mRNA was achieved using LCM and qPCR." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="33575" end="33581" sStart="null" offset="89" sid="null" wn="1" wnkey="normal%3:00:01::" text="The biological function of and any clinical significance of TYRP-1 expression in normal or malignant breast carcinomas are presently unknown." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="16490" end="16496" sStart="null" offset="288" sid="null" wn="1" wnkey="normal%3:00:01::" text="A high percentage of node-positive primary tumors (73%), metastatic carcinomas (73% and 100% concordance between primary tumor and associated metastasis, respectively), primary carcinomas without metastases (89%), benign breast specimens (70%) and normal (60%) breast specimens were positive for TYRP-1 staining (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="33575" end="33581" sStart="null" offset="89" sid="null" wn="3" wnkey="normal%3:00:03::" text="The biological function of and any clinical significance of TYRP-1 expression in normal or malignant breast carcinomas are presently unknown." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="16490" end="16496" sStart="null" offset="288" sid="null" wn="3" wnkey="normal%3:00:03::" text="A high percentage of node-positive primary tumors (73%), metastatic carcinomas (73% and 100% concordance between primary tumor and associated metastasis, respectively), primary carcinomas without metastases (89%), benign breast specimens (70%) and normal (60%) breast specimens were positive for TYRP-1 staining (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="20437" end="20443" sStart="null" offset="203" sid="r9.normal.j.0703" wn="3" wnkey="normal%3:00:03::" text="While trace amounts were detected due to the sensitivity of PCR amplification, thrombospondin transcripts were essentially absent from breast tissue epithelia obtained from normal and benign specimens, and there were no appreciable levels detected in stromal tissue components." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="23265" end="23271" sStart="null" offset="68" sid="r9.normal.j.0089" wn="3" wnkey="normal%3:00:03::" text="Having detected all three proteins immunohistochemically in normal, benign and malignant breast epithelia, the quantitation of OPN, TSP-1 and TYRP-1 mRNA was achieved using LCM and qPCR." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="33575" end="33581" sStart="null" offset="89" sid="null" wn="1" wnkey="normal%3:00:01::" text="The biological function of and any clinical significance of TYRP-1 expression in normal or malignant breast carcinomas are presently unknown." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="16490" end="16496" sStart="null" offset="288" sid="null" wn="1" wnkey="normal%3:00:01::" text="A high percentage of node-positive primary tumors (73%), metastatic carcinomas (73% and 100% concordance between primary tumor and associated metastasis, respectively), primary carcinomas without metastases (89%), benign breast specimens (70%) and normal (60%) breast specimens were positive for TYRP-1 staining (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="19340" end="19346" sStart="null" offset="128" sid="r9.normal.j.0860" wn="1" wnkey="normal%3:00:01::" text="TSP-1 expression was comparable with that of TYRP-1 in malignant cells but was at the limit of detection in normal and benign epithelia and stromal components." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="33349" end="33355" sStart="null" offset="156" sid="r9.normal.j.0552" wn="1" wnkey="normal%3:00:01::" text="It has long been known that the sera of patients who suffer from melanoma or mammary carcinoma show higher tyrosinase activity than normal sera [ 35 ] but, to our knowledge, this is the first report of TYRP-1 expression in human breast duct epithelium." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="23265" end="23271" sStart="null" offset="68" sid="r9.normal.j.0089" wn="1" wnkey="normal%3:00:01::" text="Having detected all three proteins immunohistochemically in normal, benign and malignant breast epithelia, the quantitation of OPN, TSP-1 and TYRP-1 mRNA was achieved using LCM and qPCR." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="33575" end="33581" sStart="null" offset="89" sid="null" wn="1" wnkey="normal%3:00:01::" text="The biological function of and any clinical significance of TYRP-1 expression in normal or malignant breast carcinomas are presently unknown." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="16490" end="16496" sStart="null" offset="288" sid="null" wn="2" wnkey="normal%3:00:02::" text="A high percentage of node-positive primary tumors (73%), metastatic carcinomas (73% and 100% concordance between primary tumor and associated metastasis, respectively), primary carcinomas without metastases (89%), benign breast specimens (70%) and normal (60%) breast specimens were positive for TYRP-1 staining (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="32075" end="32081" sStart="null" offset="71" sid="r9.normal.j.0702" wn="2" wnkey="normal%3:00:02::" text="TYRP-1 is a type I membrane protein expressed by melanomas and normal melanocytes that was originally characterized as an oxidase in the melanin biosynthetic pathway." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="4691" end="4697" sStart="null" offset="372" sid="r9.normal.j.0406" wn="2" wnkey="normal%3:00:02::" text="We used a combination of immunohistochemistry (IHC), LCM and real-time, quantitative PCR (qPCR) analysis of material obtained from a panel of primary breast infiltrating ductal carcinomas and nodal metastases, and compared the target gene expression levels with those found in nonmalignant diseased tissue and in samples of normal breast tissue." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="20848" end="20854" sStart="null" offset="17" sid="r9.normal.j.0178" wn="2" wnkey="normal%3:00:02::" text="P = 0.0001) over normal breast epithelia." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="23265" end="23271" sStart="null" offset="68" sid="r9.normal.j.0089" wn="2" wnkey="normal%3:00:02::" text="Having detected all three proteins immunohistochemically in normal, benign and malignant breast epithelia, the quantitation of OPN, TSP-1 and TYRP-1 mRNA was achieved using LCM and qPCR." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/bcr620.anc" start="30674" end="30678" sStart="null" offset="0" sid="null" wn="1" wnkey="lose%2:40:02::" text="A recent study confirms this to be the case in breast cancer, where expression of TSP-1 in stroma adjacent to ductal carcinoma in situ is &lt;b&gt;lost&lt;/b&gt; in cases with more aggressive histological features [ 30 ] . There are also reports, however, that fibroblast TSP-1 can induce matrix metalloproteinase-9 in breast tumor cells and gastric cancer tumor cells, and this in turn may lead to a more invasive phenotype [ 14 31 ] . In the present study, TSP-1 was not expressed differentially in the stroma of benign tissue specimens or malignant tissue specimens, nor in the epithelial component of breast tumors with or without metastases." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="20577" end="20583" sStart="null" offset="15" sid="r9.level.n.0771" wn="1" wnkey="level%1:07:00::" text="However, TSP-1 levels were significantly raised in malignant tissue epithelial sources (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="19089" end="19095" sStart="null" offset="33" sid="r9.level.n.0978" wn="1" wnkey="level%1:07:00::" text="Relative to the GAPDH transcript levels, OPN expression was found to be ~10-fold higher than TYRP-1 expression in all tissues examined." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="33825" end="33831" sStart="null" offset="9" sid="r9.level.n.0526" wn="1" wnkey="level%1:07:00::" text="Elevated levels of OPN and TSP-1 expression in primary and metastatic carcinomas suggest that these genes may be necessary for, but not sufficient for, dissemination." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/bcr620.anc" start="24532" end="24537" sStart="null" offset="0" sid="null" wn="1" wnkey="know%2:31:01::" text="Significant OPN expression has been reported in a number of breast epithelial cell lines [ 19 20 ] , and so it is &lt;b&gt;known&lt;/b&gt; that cells of breast epithelial origin can synthesize OPN in certain conditions." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="30127" end="30136" sStart="null" offset="201" sid="r11.function.n.0517" wn="3" wnkey="function%1:04:00::" text="The composition of the matrix, the availability of cytokines and proteases, and the expression of various receptors in a given cellular environment might explain these opposing functions." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="33501" end="33509" sStart="null" offset="15" sid="r11.function.n.0224" wn="2" wnkey="function%1:07:00::" text="The biological function of and any clinical significance of TYRP-1 expression in normal or malignant breast carcinomas are presently unknown." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="19529" end="19533" sStart="null" offset="27" sid="r9.fold.v.0249" wn="2147483645" wnkey="null" text="Significantly elevated (~5-fold) levels of OPN transcripts were observed in cells of epithelial origin dissected from primary carcinomas and associated metastases over nonmalignant cell sources." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="21229" end="21233" sStart="null" offset="100" sid="r9.fold.v.0963" wn="2147483645" wnkey="null" text="TYRP-1 expression was higher than that of TSP-1 but lower than that of OPN (10-fold to 50-fold)." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="21218" end="21222" sStart="null" offset="89" sid="r9.fold.v.0226" wn="" wnkey="null" text="TYRP-1 expression was higher than that of TSP-1 but lower than that of OPN (10-fold to 50-fold)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/bcr620.anc" start="3793" end="3797" sStart="null" offset="0" sid="null" wn="4" wnkey="date%1:28:02::" text="The melanogenic enzymes TYRP-1 and TYRP-2 are well-characterized differentiation antigens recognized by antibodies and T cells of patients with melanoma [ 16 ] . The evaluation of TYRP-1 expression in human breast lesions has not been documented to &lt;b&gt;date&lt;/b&gt;." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="4337" end="4348" sStart="null" offset="18" sid="r11.combination.n.0436" wn="1" wnkey="combination%1:14:00::" text="We used a combination of immunohistochemistry (IHC), LCM and real-time, quantitative PCR (qPCR) analysis of material obtained from a panel of primary breast infiltrating ductal carcinomas and nodal metastases, and compared the target gene expression levels with those found in nonmalignant diseased tissue and in samples of normal breast tissue." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="6480" end="6485" sStart="null" offset="224" sid="r10.board.n.0620" wn="1" wnkey="board%1:14:00::" text="The histological grade was assigned according to the modified Bloom-Richardson grading scheme [ 17 ] . Tissue samples were obtained and processed under approval of the UCSD Institutional Review Board for studying existing tissues (#011246X)." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr620.anc" start="9378" end="9385" sStart="null" offset="461" sid="r11.absence.n.0954" wn="1" wnkey="absence%1:26:00::" text="The optimal primer concentrations for the reference and target genes in the final PCR reaction were determined, and both dissociation curves (ABI Dissociation Curves version 1.0 software; Applied Biosystems, Foster City, CA, USA) and agarose gel electrophoretic analyses were applied to confirm the specificity of PCR products and to check for the presence of primer-dimer formations in the absence of a template." />
  </sentences>
</list>